Scrutinizing sclerotherapy.
Bowman
W E
WE
D004305:Dose-Response Relationship, Drug; D006801:Humans; D012597:Sclerosing Solutions / Q000008:administration & dosage* / Q000009:adverse effects; D015911:Sclerotherapy; D012981:Sodium Tetradecyl Sulfate / Q000008:administration & dosage* / Q000009:adverse effects; D013684:Telangiectasis / Q000628:therapy*; D014648:Varicose Veins / Q000628:therapy*
D012597:Sclerosing Solutions; D012981:Sodium Tetradecyl Sulfate